April 19, 2018
Boehringer Ingelheim Pharmaceuticals escaped a proposed class action accusing it of violating the Telephone Consumer Protection Act by sending out faxes about a free dinner meeting on sexual disorders, with a Connecticut federal judge Wednesday finding no breach of the act as the evidence showed no products were advertised at the event.